We are live on ! Find out more
TLSI icon

TriSalus Life Sciences

66 hedge funds and large institutions have $202M invested in TriSalus Life Sciences in 2021 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

46% more capital invested

Capital invested by funds: $139M → $202M (+$63.5M)

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

25% more funds holding

Funds holding: 5366 (+13)

23.85% more ownership

Funds ownership: 57.62%81.46% (+24%)

Holders
66
Holders Change
+13
Holders Change %
+24.53%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
14
Reduced
11
Closed
7
Calls
$134K
Puts
Net Calls
+$134K
Net Calls Change
+$71K
Name Holding Trade Value Shares
Change
Change in
Stake
Wellington Management Group
26
Wellington Management Group
Massachusetts
$2.13M
Point72 Asset Management
27
Point72 Asset Management
Connecticut
$1.99M
WAM
28
Weiss Asset Management
Massachusetts
$1.93M +$1.9M +194,351 New
Millennium Management
29
Millennium Management
New York
$1.85M +$1.52M +154,998 +502%
AGC
30
Angelo Gordon & Co
New York
$1.8M
CCM
31
Context Capital Management
California
$1.73M
LCM
32
Landscape Capital Management
New Jersey
$1.45M +$1.33M +135,883 +1,294%
Goldman Sachs
33
Goldman Sachs
New York
$1.35M -$363K -37,100 -21%
FTCM
34
Fir Tree Capital Management
New York
$1.24M
AA
35
AQR Arbitrage
Connecticut
$1.21M -$97.9K -10,000 -8%
DCP
36
Diameter Capital Partners
New York
$1.19M
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.18M +$1.16M +118,300 New
Hudson Bay Capital Management
38
Hudson Bay Capital Management
Connecticut
$1.16M -$529 -54 -0%
PC
39
Periscope Capital
Ontario, Canada
$1.06M +$1.05M +107,000 New
ZDA
40
Zweig-DiMenna Associates
New York
$894K +$881K +90,000 New
Jane Street
41
Jane Street
New York
$890K -$2.14K -219 -0.2%
KJHP
42
K.J. Harrison & Partners
Ontario, Canada
$799K -$587K -60,000 -43%
Nomura Holdings
43
Nomura Holdings
Japan
$713K
BCM
44
Basso Capital Management
Connecticut
$583K +$219K +22,375 +62%
WA
45
Whitebox Advisors
Minnesota
$554K +$152K +15,504 +38%
SSA
46
Schonfeld Strategic Advisors
New York
$546K +$225K +22,972 +72%
CM
47
Crestline Management
Texas
$535K +$527K +53,850 New
COPPSERS
48
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$497K
SCM
49
Segantii Capital Management
Hong Kong
$497K
Verition Fund Management
50
Verition Fund Management
Connecticut
$419K -$2.61M -267,123 -86%

TLSI Hedge Fund Activity: Q3 2021 in Review

66 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q3 2021, worth a combined $202M — up 46% from $139M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TLSI positions and 7 closed out — a net gain of 13 holders — while 14 added to existing stakes and 11 trimmed.

The largest buyer was Magnetar Financial, opening a new position worth an estimated $17.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $12.1M sold.

  • 66 institutional investors held TriSalus Life Sciences (TLSI) as of Q3 2021, up from 53 in Q2 2021.
  • Funds reported $202M of TriSalus Life Sciences stock for Q3 2021, up 46% quarter-over-quarter.
  • 20 funds opened new TriSalus Life Sciences positions in Q3 2021 and 7 closed out, a net change of +13 holders.
  • The largest TriSalus Life Sciences buyer in Q3 2021 was Magnetar Financial, an estimated $17.1M added.
  • The largest TriSalus Life Sciences seller in Q3 2021 was Park West Asset Management, an estimated $12.1M sold.

Based on aggregated 13F filings for Q3 2021.